Keros Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Keros Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Keros Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $5.18M, a 35.2% increase year-over-year.
  • Keros Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $20.6M, a 51.4% increase year-over-year.
  • Keros Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $16.9M, a 67.6% increase from 2022.
  • Keros Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $10.1M.
  • Keros Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$360K, a 132% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.9M +$6.84M +67.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $10.1M +$10.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$360K -$1.48M -132% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $1.12M +$2.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$1.77M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.